Clinical course of pregnancy, childbirth and the condition of the placenta in women with HCV-infection




HCV-infection, course of pregnancy, obstetric complications, perinatal complications


Purpose - to conduct a prospective clinical and statistical analysis of the course of pregnancy, childbirth and placental condition in women with hepatitis C virus (HCV-infection).

Materials and methods. A prospective clinical and laboratory study of the course of pregnancy, childbirth and placental condition in 40 pregnant women with HCV infection (the main group - MG) was conducted on the basis of the Kyiv City Centre for Reproductive and Perinatal Medicine for the period 2020-2022. 50 healthy pregnant women formed the control group (CG). Statistical processing of the study results was performed using standard software Microsoft Excel 5.0 and Statistica 8.0.

Results. The course of pregnancy in women of MG in the trimester I was 2 times more often complicated by early toxicosis compared with women of CG - 3 (7.5%) vs. 2 (4.0%) cases, respectively; p>0.05. The threat of pregnancy termination was 4.3 times more frequent in pregnant women of MG compared with women of CG - 7 (17.5%) vs. 2 (4.0%) cases, respectively; p<0.001. Gestational anemia occurred in 1/3 of pregnant women of MG, which was significantly higher than in pregnant women of CG - 12 (30.0%) vs. 6 (12.0%) cases, respectively; p<0.001. Pregnancy edema (mainly in the trimester III) was detected in pregnant women of MG 4.3 times more often than in pregnant women of CG - 13 (32.5%) vs. 4 (8.0%) cases, respectively; p<0.001.

Conclusions. Pregnant women with HCV infection are characterized by a significant increase in the following complications, in particular, during pregnancy: threat of abortion, threat of preterm birth, gestational anemia, placental dysfunction, fetal growth retardation syndrome, preeclampsia; during labor: premature and prenatal amniotic fluid discharge, preterm birth, weakness of labor activity.

The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patients was obtained for conducting the studies.

No conflict of interests was declared by the author.


Barritt AS, Jhaveri R. (2018). Treatment of Hepatitis C during Pregnancy-Weighing the Risks and Benefits in Contrast to HIV. Current HIV/AIDS reports. 15 (2): 155-161.; PMid:29470782

Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. (2014). Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clinical infectious diseases. 59 (6): 765-773.; PMid:24928290 PMCid:PMC4144266

Chilaka VN, Konje JC. (2021). Viral Hepatitis in pregnancy. European journal of obstetrics, gynecology, and reproductive biology. 256: 287-296.; PMid:33259998

Compagnone A, Catenazzi P, Riccardi R, Zuppa AA. (2019). Mother-to-child transmission of hepatitis C virus. Minerva pediatrica. 71 (2): 174-180.; PMid:29968442

Dibba P, Cholankeril R, Li AA, Patel M, Fayek M, Dibble C, Okpara N, Hines A, Ahmed A. (2018). Hepatitis C in Pregnancy. Diseases (Basel, Switzerland). 6 (2): 31.; PMid:29702563 PMCid:PMC6023348

El-Shabrawi M, Kamal NM, Mogahed EA, Elhusseini MA, Aljabri MF. (2019). Perinatal transmission of hepatitis C virus: an update. Archives of medical science: AMS. 16 (6): 1360-1369.; PMid:33224335 PMCid:PMC7667440

Freriksen J, van Seyen M, Judd A, Gibb DM, Collins IJ, Greupink R, Russel F, Drenth J, Colbers, A, Burger DM. (2019). Review article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation - implications for maternal dosing, foetal exposure, and safety for mother and child. Alimentary pharmacology & therapeutics. 50 (7): 738-750. PMid:31448450 PMCid:PMC6773363

Gowda C, Smith S, Crim L, Moyer K, Sánchez PJ, Honegger JR. (2021). Nucleic Acid Testing for Diagnosis of Perinatally Acquired Hepatitis C Virus Infection in Early Infancy. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 73 (9): e3340-e3346.; PMid:32640018 PMCid:PMC8563185

Hofstraat S, Falla AM, Duffell EF, Hahné S, Amato-Gauci AJ, Veldhuijzen IK, Tavoschi L. (2017). Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review. Epidemiology and infection. 145 (14): 2873-2885.; PMid:28891457 PMCid:PMC5647665

Huang QT, Hang LL, Zhong M, Gao YF, Luo ML, Yu YH. (2016). Maternal HCV infection is associated with intrauterine fetal growth disturbance: A meta-analysis of observational studies. Medicine. 95 (35): e4777.; PMid:27583932 PMCid:PMC5008616

Huang QT, Huang Q, Zhong M, Wei SS, Luo W, Li F, Yu YH. (2015). Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta-analysis of observational studies. Journal of viral hepatitis. 22 (12): 1033-1042.; PMid:26081198

Jhaveri R, Swamy GK. (2014). Hepatitis C Virus in Pregnancy and Early Childhood: Current Understanding and Knowledge Deficits. Journal of the Pediatric Infectious Diseases Society. 3 (1): S13-S18.; PMid:25232471 PMCid:PMC4164177

Kanninen TT, Dieterich D, Asciutti S. (2015). HCV vertical transmission in pregnancy: New horizons in the era of DAAs. Hepatology (Baltimore, Md.). 62 (6): 1656-1658.; PMid:26238474

Le Campion A, Larouche A, Fauteux-Daniel S, Soudeyns H. (2012). Pathogenesis of hepatitis C during pregnancy and childhood. Viruses. 4 (12): 3531-3550.; PMid:23223189 PMCid:PMC3528278

Mamatova MR, Muftaidinova ShK, Mamadieva MS. (2017). Obstetric and perinatal outcomes in women with viral hepatitis C. Young scientist. 16 (150): 55-57.

Mateyko HB, Matvisiv MV. (2017). Risk of the fetus and newborn infection in pregnant women with HBV- and HCV-infection. Infectious diseases. 2: 9-14.

Mavilia MG, Wu GY. (2017). Mechanisms and Prevention of Vertical Transmission in Chronic Viral Hepatitis. Journal of clinical and translational hepatology. 5 (2): 119-129.; PMid:28660149 PMCid:PMC5472932

Mintser AP. (2018). Statisticheskie metodyi issledovaniya v klinicheskoy meditsine. Prakticheskaya meditsina. 3: 41-45.

Money D, Boucoiran I, Wagner E, Dobson S, Kennedy A, Lohn Z, Krajden M, Yoshida EM. (2014). Obstetrical and neonatal outcomes among women infected with hepatitis C and their infants. Journal of obstetrics and gynaecology Canada: JOGC = Journal d'obstetrique et gynecologie du Canada: JOGC. 36 (9): 785-794.; PMid:25222357

Prasad MR, Honegger JR. (2013). Hepatitis C virus in pregnancy. American journal of perinatology. 30 (2): 149-159.; PMid:23389935 PMCid:PMC3862252

Public Health Center. (2018). Hepatitis C in Ukraine: epidemiological characteristics and severity assessment. URL:

Ragusa R, Corsaro LS, Frazzetto E, Bertino E, Bellia MA, Bertino G. (2020). Hepatitis C Virus Infection in Children and Pregnant Women: An Updated Review of the Literature on Screening and Treatments. AJP reports. 10 (1): e121-e127.; PMid:32257593 PMCid:PMC7108952

Rahim MN, Pirani T, Williamson C, Heneghan MA. (2021). Management of pregnancy in women with cirrhosis. United European gastroenterology journal. 9 (1): 110-119.; PMid:33259738 PMCid:PMC8259114

Reid S, Day CA, Bowen DG, Minnis J, Ludlow J, Jacobs S, Gordon A, Haber PS. (2018). Vertical transmission of hepatitis C: Testing and health-care engagement. Journal of paediatrics and child health. 54 (6): 647-652.; PMid:29292561

Roudot-Thoraval F. (2021). Epidemiology of hepatitis C virus infection. Clinics and research in hepatology and gastroenterology. 45 (3): 101596.; PMid:33610022

WHO. (2017). Global hepatitis report.

Wijarnpreecha K, Thongprayoon C, Sanguankeo A, Upala S, Ungprasert P, Cheungpasitporn W. (2017). Hepatitis C infection and intrahepatic cholestasis of pregnancy: A systematic review and meta-analysis. Clinics and research in hepatology and gastroenterology. 41 (1): 39-45.; PMid:27542514

Znovets TV, Baranovskaya EI, Zhavoponok CB, Znovets IA. (2018). Perinatal outcomes of HCV infection. Medical Journal. 4: 57-61.